# New York Presbyterian Hospital Services – FDA Inspection, Sep 10, 2025

Source: https://www.keypedia.com/records/fda_inspections/new-york-presbyterian-hospital-services/380016a7-cf2e-495e-a359-348108916766
Source feed: FDA_Inspections

> FDA inspection 1281114 of New York Presbyterian Hospital Services, September 10, 2025. Classification: No Action Indicated (NAI). 2 citations under 21 CFR part 606. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1281114
- Company Name: New York Presbyterian Hospital Services
- Inspection Date: 2025-09-10
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: New York District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1215867 - 2023-08-21
- FDA Inspection 1080428 - 2019-02-07
- FDA Inspection 990270 - 2016-10-28

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/new-york-presbyterian-hospital-services/70fbb123-9a97-4163-9b57-adc163fbfda6

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d
